Immunoblotting of mammary tumour chunks showed dramatic upregulation of HIF1α that was concomitant with increased VIM, SNAI1, TWIST and decreased E-CAD expression in GPx2 KD relative to control tumours (Fig. 2a). Here, GPX2 is linked to breast cancer.